Taclonex FDA Approval History
FDA Approved: Yes (First approved January 9, 2006)
Brand name: Taclonex
Generic name: calcipotriene and betamethasone dipropionate
Dosage form: Ointment
Company: LEO Pharma
Treatment for: Psoriasis
Taclonex is a topical ointment containing a combination of calcipotriene and betamethasone for the treatment of psoriasis vulgaris in adults.
Development Timeline for Taclonex
|May 12, 2008||FDA Approves Taclonex Scalp - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis|
|Jan 11, 2006||FDA Approves Taclonex - Once Daily Therapy for Treatment of Psoriasis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.